Capsugel and Pulmatrix ($PULM) have teamed up to develop new inhaled therapies for COPD, cystic fibrosis and idiopathic pulmonary fibrosis. News
> Cambridge, MA's Seven Bridges raised $45 million to support its large-scale genomics platform. More
> Drugmaker Athenex is planning to build a manufacturing plant in New York after securing a $225 million investment from the state. Item
